LENZ Therapeutics, Inc. (LENZ) Free Cash Flow (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Free Cash Flow for 2 consecutive years, with -$21.0 million as the latest value for Q4 2023.
- On a quarterly basis, Free Cash Flow rose 10.45% to -$21.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$60.4 million, a 36.12% increase, with the full-year FY2024 number at -$59.9 million, up 0.91% from a year prior.
- Free Cash Flow was -$21.0 million for Q4 2023 at LENZ Therapeutics, down from -$13.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$12.8 million in Q1 2023 to a low of -$24.5 million in Q1 2022.